The impact of long-term gonadotropin-releasing hormone analogue treatment on preclinical abortions in patients with severe endometriosis undergoing in vitro fertilization-embryo transfer

D Dicker, Dicker D, Dov Dicker, Goldman JA, J A Goldman, Jack A. Goldman, T Levy, Levy T, Tally Levy, D Feldberg, Feldberg D, Dov Feldberg, Jacob Ashkenazi, J Ashkenazi, Ashkenazi J
Fertility and sterility · 1992 · vol. 57(3) , pp. 597–600 · doi:10.1016/s0015-0282(16)54906-1 · PMID:1740204 · W2404983744
article OA: closed CC0 ⤵ 80 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-07 ⓘ

This study investigated the effect of long-term GnRH analogue treatment on preclinical abortions in severe endometriosis patients undergoing IVF-ET.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

ObjectiveTo examine the relationship between endometriosis and preclinical abortions and to evaluate the effect of gonadotropin-releasing hormone analogue (GnRH-a) therapy on these pregnancies.Design and patientsOf 67 women with severe endometriosis referred to us for in vitro fertilization-embryo transfer (IVF-ET), 32 underwent ovarian stimulation for oocyte retrieval with menotropins (protocol A), whereas the other 35 were admitted for the procedure after a 6-month period of hormonal suppression with a GnRH agonist (protocol B). The clinical impact of the preclinical and clinical pregnancies in both treatment protocols were evaluated on the basis of oocyte classification and embryo quality score.SettingAll patients were treated in our IVF Unit.Main outcome measureClinical pregnancy was used as our main outcome measure of success.ResultsA significantly higher number of preclinical pregnancies (P less than 0.0001) occurred in patients treated by protocol A. After GnRH-a treatment, the preclinical pregnancy rate declined significantly (P less than 0.0001), whereas the clinical pregnancy rate per cycle and per transfer rose significantly (P less than 0.0001 and P less than 0.0001, respectively). Furthermore, clinical pregnancies had a significantly better mean embryo quality score in comparison with preclinical pregnancies (P less than 0.0001).ConclusionsIt is concluded that combining GnRH-a therapy before IVF-ET provides an improved treatment modality for preclinical abortions and infertility associated with severe endometriosis.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Abortion, Spontaneous Embryo Transfer Endometriosis Fertilization in Vitro Gonadotropin-Releasing Hormone Pregnancy Complications Triptorelin Pamoate Triptorelin Pamoate Adult Delayed-Action Preparations Endometriosis Endometriosis Female Gonadotropin-Releasing Hormone Gonadotropin-Releasing Hormone Humans Pregnancy Pregnancy Complications Pregnancy Complications Pregnancy Outcome

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (20)

Cited by (50)

Source provenance

europepmc
last seen: 2026-08-04T06:16:37.499272+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:11:49.821429+00:00
License: CC0 · commercial use OK